End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
21.74 USD | -0.69% | -0.82% | +109.04% |
May. 16 | HC Wainwright Initiates Dianthus Therapeutics With Buy Rating, $40 Price Target | MT |
May. 10 | Wedbush Adjusts Dianthus Therapeutics' Price Target to $38 From $33, Keeps Outperform Rating | MT |
Financials (USD)
Sales 2024 * | 1.82M | Sales 2025 * | 1.98M | Capitalization | 638M |
---|---|---|---|---|---|
Net income 2024 * | -63M | Net income 2025 * | -88M | EV / Sales 2024 * | 178 x |
Net cash position 2024 * | 314M | Net cash position 2025 * | 518M | EV / Sales 2025 * | 60.5 x |
P/E ratio 2024 * |
-9.91
x | P/E ratio 2025 * |
-8.36
x | Employees | 53 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.16% |
1 day | +1.89% | ||
1 week | -0.82% | ||
Current month | +0.60% | ||
1 month | -15.74% | ||
3 months | -14.61% | ||
6 months | +130.05% | ||
Current year | +109.04% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-04 | 21.74 | -0.69% | 152,252 |
24-06-03 | 21.89 | +1.30% | 178,190 |
24-05-31 | 21.61 | +4.40% | 229,868 |
24-05-30 | 20.7 | -6.59% | 154,451 |
24-05-29 | 22.16 | +1.09% | 58,780 |
End-of-day quote Nasdaq, June 03, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+109.04% | 638M | |
+18.60% | 123B | |
+15.29% | 107B | |
-3.69% | 24.01B | |
+2.18% | 22.59B | |
-10.09% | 18.16B | |
-41.04% | 16.84B | |
-12.55% | 16.23B | |
+3.87% | 13.43B | |
+25.29% | 11.32B |
- Stock Market
- Equities
- DNTH Stock